Neuromodulation and Research Fellow

at  York and Scarborough Teaching Hospitals NHS Foundation Trust

We are delighted to offer a Neuromodulation Research Fellowship at York and Scarborough Teaching Hospitals NHS Trust. This 1-year industry funded post is looking to further the development of expertise in, and a strong evidence base for, neuromodulation.
The ideal applicant must hold a UK CCT in Anaesthesia and pain medicine or equivalent. The successful candidate will gain the exposure, experience, and confidence to become an independent neuromodulator. The candidate will learn how a successful service with low explant rates and high patient satisfaction is run. Further, this role will give the candidate dedicated time to undertake, publish and present neuromodulation research.
The fellowship will have protected time for high quality supervised research that will align with both local and industry research priorities. Within the post, they will be expected to engage and deliver NIHR portfolio studies related to pain and neuromodulation. However, they will also be required to develop and deliver investigator initiated, industry funded studies that align with the strategic direction of both the funder and the neuromodulation service. This position presently joint funded by Saluda medical, Nevro & Mainstay medical will help fill the current void in well designed and conducted randomised controlled trials in this sphere. This aligns with the recent publications in major journals (JAMA) and discussion at international meetings (INS) calling for this direction. York and Scarborough NHS Foundation Trust has a strong history in delivering randomised controlled trials (both commercial & non-commercial) in the sphere of Anaesthesia, Pain, Perioperative medicine, and Intensive Care and has several active trials ongoing. We successfully deliver many NIHR portfolio trials across our trust, a number of which have been developed and sponsored by York and Scarborough NHS Foundation Trust.
The successful applicant will be supported by both the University of York academically & Dr Armstrong and Dr Fitzmaurice clinically, & will be encouraged to attend & present their research regularly at major national & international meetings including NSUKI, BPS, INS, NANS and WIP
Our benefits

• To create a competent independent implanter in all neuromodulation devices.
• To support and grow our research portfolio